KB Baumgartner, JM Samet, CA Stidley, TV Colby and JA Waldron
Division of Epidemiology and Cancer Control, University of New Mexico Health Sciences Center, Albuquerque 87131-5306, USA.

We conducted a multicenter case-control study of clinically and histologically diagnosed idiopathic pulmonary fibrosis (IPF), a chronic diffuse interstitial lung disease of unknown cause. The study included 248 cases, and 491 control subjects identified through random-digit dialing, matched to cases in sex, age, and geographic region. Telephone interviews were conducted with both cases and controls to collect information on potential risk factors for IPF, including smoking and household, occupational, and environmental exposures. Pulmonary function tests, X-rays, computed tomographic (CT) scans of the chest, and lung biopsy reports were submitted by referring centers to support the diagnoses. An a priori hypothesis that smoking is associated with IPF was examined with conditional logistic regression analyses. More cases (72%) than control subjects (63%) had a history of ever smoking. The odds ratio (OR) for ever smoking was 1.6 (95% CI: 1.1 to 2.4). Risk was significantly elevated for former smokers (OR = 1.9; 95% CI: 1.3 to 2.9) and for smokers with 21 to 40 pack-yr (OR = 2.3; 95% CI: 1.3 to 3.8). A history of smoking is associated with an increased risk for the development of IPF. Although there was no clear exposure-response pattern with cumulative consumption of cigarettes, there was a trend for time since cessation of smoking, with the highest risk for those who had most recently quit.

This article has been cited by other articles:

				D. J. Lederer, P. L. Enright, S. M. Kawut, E. A. Hoffman, G. Hunninghake, E. J. R. van Beek, J. H. M. Austin, R. Jiang, G. S. Lovasi, and R. G. Barr Cigarette Smoking Is Associated with Subclinical Parenchymal Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study Am. J. Respir. Crit. Care Med., September 1, 2009; 180(5): 407 - 414. [Abstract] [Full Text] [PDF]

				K. MIYAZAKI, H. SATOH, K. KURISHIMA, R. NAKAMURA, H. ISHIKAWA, K. KAGOHASHI, G. OHARA, and N. HIZAWA Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer Anticancer Res, July 1, 2009; 29(7): 2671 - 2674. [Abstract] [Full Text] [PDF]

				M. Akira, Y. Inoue, M. Kitaichi, S. Yamamoto, T. Arai, and K. Toyokawa Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia with and without Concurrent Emphysema: Thin-Section CT Findings Radiology, April 1, 2009; 251(1): 271 - 279. [Abstract] [Full Text] [PDF]

				E. Savarino, M. Bazzica, P. Zentilin, D. Pohl, A. Parodi, G. Cittadini, S. Negrini, F. Indiveri, R. Tutuian, V. Savarino, et al. Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma: A Study Using pH-Impedance Monitoring Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 408 - 413. [Abstract] [Full Text] [PDF]

				J. P. Lynch III Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 635 - 686. [Full Text] [PDF]

				J. T. Cronkhite, C. Xing, G. Raghu, K. M. Chin, F. Torres, R. L. Rosenblatt, and C. K. Garcia Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 729 - 737. [Abstract] [Full Text] [PDF]

				A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui Interstitial lung disease guideline Thorax, September 1, 2008; 63(Suppl_5): v1 - v58. [Full Text] [PDF]

				K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194. [Abstract] [Full Text] [PDF]

				C. K. Garcia, W. E. Wright, and J. W. Shay Human diseases of telomerase dysfunction: insights into tissue aging Nucleic Acids Res., December 3, 2007; 35(22): 7406 - 7416. [Abstract] [Full Text] [PDF]

				A. U Wells, A. G Nicholson, and D. M Hansell Challenges in pulmonary fibrosis {middle dot} 4: Smoking-induced diffuse interstitial lung diseases Thorax, October 1, 2007; 62(10): 904 - 910. [Abstract] [Full Text] [PDF]

				G. W. Hunninghake and M. I. Schwarz State of the Art. Does Current Knowledge Explain the Pathogenesis of Idiopathic Pulmonary Fibrosis?: A Perspective Proceedings of the ATS, August 15, 2007; 4(5): 449 - 452. [Abstract] [Full Text] [PDF]

				P. Tonnesen, L. Carrozzi, K. O. Fagerstrom, C. Gratziou, C. Jimenez-Ruiz, S. Nardini, G. Viegi, C. Lazzaro, I. A. Campell, E. Dagli, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy Eur. Respir. J., February 1, 2007; 29(2): 390 - 417. [Abstract] [Full Text] [PDF]

				H. Sumikawa, T. Johkoh, K. Ichikado, H. Taniguchi, Y. Kondoh, K. Fujimoto, U. Tateishi, T. Hiramatsu, A. Inoue, J. Natsag, et al. Usual Interstitial Pneumonia and Chronic Idiopathic Interstitial Pneumonia: Analysis of CT Appearance in 92 Patients Radiology, October 1, 2006; 241(1): 258 - 266. [Abstract] [Full Text] [PDF]

				G. Raghu, T. D. Freudenberger, S. Yang, J. R. Curtis, C. Spada, J. Hayes, J. K. Sillery, C. E. Pope II, and C. A. Pellegrini High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis Eur. Respir. J., January 1, 2006; 27(1): 136 - 142. [Abstract] [Full Text] [PDF]

				D. S. Kim, H. R. Collard, and T. E. King Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proceedings of the ATS, January 1, 2006; 3(4): 285 - 292. [Abstract] [Full Text] [PDF]

				V. S. Taskar and D. B. Coultas Is idiopathic pulmonary fibrosis an environmental disease? Proceedings of the ATS, January 1, 2006; 3(4): 293 - 298. [Abstract] [Full Text] [PDF]

				A. Caminati and S. Harari Smoking-related Interstitial Pneumonias and Pulmonary Langerhans Cell Histiocytosis. Proceedings of the ATS, January 1, 2006; 3(4): 299 - 306. [Abstract] [Full Text] [PDF]

				V. Cottin, H. Nunes, P-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblond, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J-F. Cordier, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur. Respir. J., October 1, 2005; 26(4): 586 - 593. [Abstract] [Full Text] [PDF]

				L. Tiitto, U. Heiskanen, R. Bloigu, P. Paakko, V. Kinnula, and R. Kaarteenaho-Wiik Thoracoscopic Lung Biopsy Is a Safe Procedure in Diagnosing Usual Interstitial Pneumonia Chest, October 1, 2005; 128(4): 2375 - 2380. [Abstract] [Full Text] [PDF]

				Y. MIYAKE, S. SASAKI, T. YOKOYAMA, K. CHIDA, A. AZUMA, T. SUDA, S. KUDOH, N. SAKAMOTO, K. OKAMOTO, G. KOBASHI, et al. Occupational and Environmental Factors and Idiopathic Pulmonary Fibrosis in Japan Ann. Hyg., April 1, 2005; 49(3): 259 - 265. [Abstract] [Full Text] [PDF]

				N J Screaton and T Koh Emphysema and smoking-related lung diseases Imaging, October 1, 2004; 16(1): 50 - 60. [Abstract] [Full Text] [PDF]

				N. Khalil and R. O'Connor Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment Can. Med. Assoc. J., July 20, 2004; 171(2): 153 - 160. [Abstract] [Full Text] [PDF]

				J.-H. Chen, T.-H. Tseng, Y.-C. Ho, H.-H. Lin, W.-L. Lin, and C.-J. Wang Gaseous Nitrogen Oxides Stimulate Cell Cycle Progression by Rubidium Phosphorylation via Activation of Cyclins/Cdks Toxicol. Sci., November 1, 2003; 76(1): 83 - 90. [Abstract] [Full Text] [PDF]

				J. Cisneros-Lira, M. Gaxiola, C. Ramos, M. Selman, and A. Pardo Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L949 - L956. [Abstract] [Full Text] [PDF]

				T. Enomoto, J. Usuki, A. Azuma, T. Nakagawa, and S. Kudoh Diabetes Mellitus May Increase Risk for Idiopathic Pulmonary Fibrosis Chest, June 1, 2003; 123(6): 2007 - 2011. [Abstract] [Full Text] [PDF]

				T. Vehmas, L. Kivisaari, M.S. Huuskonen, and M.S. Jaakkola Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers Eur. Respir. J., May 1, 2003; 21(5): 866 - 871. [Abstract] [Full Text] [PDF]

				M. R. Khoshnevis, T. E. King Jr., and J. Tooze Histopathology and prediction of survival in usual interstitial pneumonia Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1451 - 1452. [Full Text] [PDF]

				K. Uematsu, A. Yoshimura, A. Gemma, H. Mochimaru, Y. Hosoya, S. Kunugi, K. Matsuda, M. Seike, F. Kurimoto, K. Takenaka, et al. Aberrations in the Fragile Histidine Triad (FHIT) Gene in Idiopathic Pulmonary Fibrosis Cancer Res., December 1, 2001; 61(23): 8527 - 8533. [Abstract] [Full Text] [PDF]

				T. E. KING JR., J. A. TOOZE, M. I. SCHWARZ, K. R. BROWN, and R. M. CHERNIACK Predicting Survival in Idiopathic Pulmonary Fibrosis . Scoring System and Survival Model Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1171 - 1181. [Abstract] [Full Text] [PDF]

				T. E. KING JR., M. I. SCHWARZ, K. BROWN, J. A. TOOZE, T. V. COLBY, J. A. WALDRON JR., A. FLINT, W. THURLBECK, and R. M. CHERNIACK Idiopathic Pulmonary Fibrosis . Relationship between Histopathologic Features and Mortality Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1025 - 1032. [Abstract] [Full Text] [PDF]

				B. A. Rajasekaran, D. Shovlin, P. Lord, and C. A. Kelly Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis Rheumatology, September 1, 2001; 40(9): 1022 - 1025. [Abstract] [Full Text] [PDF]

				G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s. [Abstract] [Full Text] [PDF]

				R.M. du Bois and A.U. Wells Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Eur. Respir. J., July 1, 2001; 18(32_suppl): 43S - 55s. [Abstract] [Full Text] [PDF]

				E. D. Chan, A. H. Ralston, and L. Shapiro Does Reduced {alpha}1-Antitrypsin Activity Explain the Link Between Cigarette Smoking and Idiopathic Pulmonary Fibrosis? Chest, July 1, 2001; 120 (2009): 72S - 74S. [Full Text] [PDF]

				J. Park, D.S. Kim, T.S. Shim, C-M. Lim, Y. Koh, S.D. Lee, W.S. Kim, W.D. Kim, J.S. Lee, and K.S. Song Lung cancer in patients with idiopathic pulmonary fibrosis Eur. Respir. J., June 1, 2001; 17(6): 1216 - 1219. [Abstract] [Full Text] [PDF]

				M. Selman, T. E. King Jr., and A. Pardo Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Ann Intern Med, January 16, 2001; 134(2): 136 - 151. [Abstract] [Full Text] [PDF]

				J.H. Ryu, T.V. Colby, T.E. Hartman, and R. Vassallo Smoking-related interstitial lung diseases: a concise review Eur. Respir. J., January 1, 2001; 17(1): 122 - 132. [Abstract] [Full Text] [PDF]

				R. Hubbard and A. Venn Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK General Practice Research Database Thorax, October 1, 2000; 55(10): 864 - 866. [Abstract] [Full Text]

				S. C Bourke and H. Clague Review of cryptogenic fibrosing alveolitis, including current treatment guidelines Postgrad. Med. J., October 1, 2000; 76(900): 618 - 624. [Full Text]

				D. A. VASSILAKIS, G. SOURVINOS, D. A. SPANDIDOS, N. M. SIAFAKAS, and D. BOUROS Frequent Genetic Alterations at the Microsatellite Level in Cytologic Sputum Samples of Patients with Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1115 - 1119. [Abstract] [Full Text]

				K. B. Baumgartner, J. M. Samet, D. B. Coultas, C. A. Stidley, W. C. Hunt, T. V. Colby, J. A. Waldron, and Collaborating Centers Occupational and Environmental Risk Factors for Idiopathic Pulmonary Fibrosis: A Multicenter Case-Control Study Am. J. Epidemiol., August 15, 2000; 152(4): 307 - 315. [Abstract] [Full Text] [PDF]

				T. E. King, R. Ziesche, L.-H. Block, and R.M. d. Bois Interferon Gamma-1b for the Treatment of Idiopathic Pulmonary Fibrosis N. Engl. J. Med., March 30, 2000; 342(13): 974 - 975. [Full Text]

				T. King Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664. [Full Text]

				J. M. Samet Does Idiopathic Pulmonary Fibrosis Increase Lung Cancer Risk? Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 1 - 1. [Full Text] [PDF]

				R. HUBBARD, A. VENN, S. LEWIS, and J. BRITTON Lung Cancer and Cryptogenic Fibrosing Alveolitis . A Population-based Cohort Study Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 5 - 8. [Abstract] [Full Text]

				J. Moon, R. M du Bois, T. V Colby, D. M Hansell, and A. G Nicholson Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease Thorax, November 1, 1999; 54(11): 1009 - 1014. [Abstract] [Full Text]

				D. W Mapel, W. C Hunt, R. Utton, K. B Baumgartner, J. M Samet, and D. B Coultas Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts Thorax, June 1, 1998; 53(6): 469 - 476. [Abstract] [Full Text]

				G. R. Epler and E. J. Mark Case 11-1998- A 35-Year-Old Woman with Obstructive Pulmonary Disease and Cystic Changes on CT Scans of the Chest N. Engl. J. Med., April 9, 1998; 338(15): 1051 - 1058. [Full Text] [PDF]

				P. A. WARD and G. W. HUNNINGHAKE Lung Inflammation and Fibrosis Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S123 - S129. [Full Text] [PDF]

				M. King, J Jessurun, and M. Hertz Recurrence of desquamative interstitial pneumonia after lung transplantation Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 2003 - 2005. [Full Text]

				M. Remy-Jardin, J.-L. Edme, C. Boulenguez, J. Remy, I. Mastora, and A. Sobaszek Longitudinal Follow-up Study of Smoker's Lung with Thin-Section CT in Correlation with Pulmonary Function Tests Radiology, January 1, 2002; 222(1): 261 - 270. [Abstract] [Full Text] [PDF]